D.E. Shaw & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-228,325
| Closed | -$21.2M | – | 6199 |
|
|
2021
Q4 | $21.2M | Buy |
+228,325
| New | +$15M | 0.02% | 1051 |
|
|
2021
Q3 | – | Sell |
-6,347
| Closed | -$433K | – | 5520 |
|
|
2021
Q2 | $433K | Sell |
6,347
-1,744
| -22% | -$114K | ﹤0.01% | 4105 |
|
|
2021
Q1 | $561K | Buy |
+8,091
| New | +$623K | ﹤0.01% | 3455 |
|
|
2020
Q1 | – | Sell |
-31,777
| Closed | -$1.44M | – | 4394 |
|
|
2019
Q4 | $1.44M | Buy |
31,777
+16,522
| +108% | +$781K | ﹤0.01% | 2726 |
|
|
2019
Q3 | $698K | Sell |
15,255
-5,533
| -27% | -$311K | ﹤0.01% | 3044 |
|
|
2019
Q2 | $1.22M | Buy |
+20,788
| New | +$1.07M | ﹤0.01% | 2557 |
|
|
2018
Q1 | – | Sell |
-81,828
| Closed | -$2.78M | – | 3871 |
|
|
2017
Q4 | $2.78M | Buy |
81,828
+50,888
| +164% | +$1.45M | ﹤0.01% | 1893 |
|
|
2017
Q3 | $789K | Sell |
30,940
-7,030
| -19% | -$161K | ﹤0.01% | 2646 |
|
|
2017
Q2 | $641K | Buy |
37,970
+27,919
| +278% | +$383K | ﹤0.01% | 2685 |
|
|
2017
Q1 | $147K | Buy |
10,051
+309
| +3% | +$4.58K | ﹤0.01% | 3164 |
|
|
2016
Q4 | $138K | Buy |
9,742
+7,722
| +382% | +$120K | ﹤0.01% | 3323 |
|
|
2016
Q3 | $35K | Buy |
+2,020
| New | +$33.5K | ﹤0.01% | 3327 |
|
|
2016
Q1 | – | Sell |
-3,749
| Closed | -$71K | – | 3883 |
|
|
2015
Q4 | $71K | Sell |
3,749
-5,806
| -61% | -$118K | ﹤0.01% | 3699 |
|
|
2015
Q3 | $183K | Sell |
9,555
-13,992
| -59% | -$475K | ﹤0.01% | 3514 |
|
|
2015
Q2 | $1.09M | Sell |
23,547
-89,312
| -79% | -$3.87M | ﹤0.01% | 2643 |
|
|
2015
Q1 | $4.93M | Sell |
112,859
-5,549
| -5% | -$258K | 0.01% | 1393 |
|
|
2014
Q4 | $4.11M | Buy |
118,408
+98,098
| +483% | +$3.98M | 0.01% | 1713 |
|
|
2014
Q3 | $851K | Sell |
20,310
-29,981
| -60% | -$1.34M | ﹤0.01% | 2941 |
|
|
2014
Q2 | $2.95M | Sell |
50,291
-20,194
| -29% | -$1.27M | ﹤0.01% | 2001 |
|
|
2014
Q1 | $4.44M | Buy |
70,485
+5,141
| +8% | +$341K | 0.01% | 1691 |
|
|
2013
Q4 | $3.82M | Buy |
+65,344
| New | +$3.41M | 0.01% | 1920 |
|
D.E. Shaw & Co's ARNA Position: Q1 2022 in Review
D.E. Shaw & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 228,325 shares — an estimated $21.2M sold.
D.E. Shaw & Co first reported a position in ARNA in Q4 2013 and held it in 21 quarters. The position peaked at $21.2M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- D.E. Shaw & Co reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 228,325 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $21.2M.
- D.E. Shaw & Co first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 21 quarters.
- D.E. Shaw & Co's Arena Pharmaceuticals Inc position peaked at $21.2M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.